The Journal of Immunology, Vol 137, Issue 3 858-862, Copyright © 1986 by American Association of Immunologists

ARTICLES

Interleukin 1: a regulatory role in glucocorticoid-regulated hepatic metabolism

MR Hill, RD Stith and RE McCallum

The purpose of this study was to investigate the effect of interleukin 1 (IL 1) on glucocorticoid-regulated hepatic metabolism. Steroid binding in liver cytosol, plasma glucose, plasma corticosterone, and phosphoenolpyruvate carboxykinase (PEPCK) activity were assayed in C3H/HeJ mice after IL 1 administration. Mice received 5 pyrogenic U (PU) of rabbit IL 1 i.p. and were sacrificed 4 hr later. In adrenal- intact mice, steroid binding and plasma glucose were significantly decreased (63 and 64% of control) and plasma corticosterone was significantly elevated threefold. In adrenalectomized mice, IL 1 (5 PU) treatment produced similar results in steroid binding (66% of control) and plasma glucose (71% of control). PEPCK was measured in intact mice fasted overnight and treated with 5 PU of IL 1. PEPCK was induced in fasted control animals (23.1 +/- 1.4 U/mg) vs fed control animals (15.9 +/- 0.7 U/mg). IL 1 treatment inhibited the induction of PEPCK in fasted animals (13.4 +/- 2.0 U/mg) and caused a significant decrease in steroid binding (78% of fasted control) and plasma glucose (82% of fasted control). No difference in plasma corticosterone was seen in IL 1-treated mice and fasted control mice. These data indicate that IL 1 decreases intracellular steroid receptors, resulting in decreased induction of PEPCK and subsequent reduced gluconeogenesis and plasma glucose. We propose that IL 1 plays a regulatory role in glucocorticoid- regulated hepatic metabolism.

This article has been cited by other articles:

				J. Yan, Z. Gao, G. Yu, Q. He, J. Weng, and J. Ye Nuclear Corepressor Is Required for Inhibition of Phosphoenolpyruvate Carboxykinase Expression by Tumor Necrosis Factor-{alpha} Mol. Endocrinol., July 1, 2007; 21(7): 1630 - 1641. [Abstract] [Full Text] [PDF]

				S. Oguri, K. Motegi, Y. Iwakura, and Y. Endo Primary Role of Interleukin-1{alpha} and Interleukin-1{beta} in Lipopolysaccharide-Induced Hypoglycemia in Mice Clin. Vaccine Immunol., November 1, 2002; 9(6): 1307 - 1312. [Abstract] [Full Text] [PDF]

				K. Reynolds, B. Novosad, A. Hoffhines, J. Gipson, J. Johnson, J. Peters, F. Gonzalez, J. Gimble, and M. Hill Pretreatment with troglitazone decreases lethality during endotoxemia in mice Innate Immunity, August 1, 2002; 8(4): 307 - 314. [Abstract] [PDF]

				C. M. Pariante, B. D. Pearce, T. L. Pisell, C. I. Sanchez, C. Po, C. Su, and A. H. Miller The Proinflammatory Cytokine, Interleukin-1{alpha}, Reduces Glucocorticoid Receptor Translocation and Function Endocrinology, September 1, 1999; 140(9): 4359 - 4366. [Abstract] [Full Text]

				M. R. Hill, S. Clarke, K. Rodgers, B. Thornhill, J. M. Peters, F. J. Gonzalez, and J. M. Gimble Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia Infect. Immun., July 1, 1999; 67(7): 3488 - 3493. [Abstract] [Full Text] [PDF]

				A. Ito, T. Takii, T. Matsumura, and K. Onozaki Augmentation of Type I IL-1 Receptor Expression and IL-1 Signaling by IL-6 and Glucocorticoid in Murine Hepatocytes J. Immunol., April 1, 1999; 162(7): 4260 - 4265. [Abstract] [Full Text] [PDF]

				C. M. Pariante, B. D. Pearce, T. L. Pisell, M. J. Owens, and A. H. Miller Steroid-Independent Translocation of the Glucocorticoid Receptor by the Antidepressant Desipramine Mol. Pharmacol., October 1, 1997; 52(4): 571 - 581. [Abstract] [Full Text]

				E. Bernton, J. Beach, J. Holaday, R. Smallridge, and H. Fein Release of multiple hormones by a direct action of interleukin-1 on pituitary cells Science, October 23, 1987; 238(4826): 519 - 521. [Abstract] [PDF]